| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 49.601.478 $ | -973.261 $ | +10,7 % | 5 | 50.574.739 $ | -17.373.033 $ | +123,6 % | 5 | 67.947.772 $ | +29.820.952 $ | +107,2 % | 5 | ||||
| LENZ Therapeutics, Inc. | LENZ | → 0 | Neutral | 9.312.422 $ | -6.971.594 $ | -42,8 % | 1 | 16.284.016 $ | -31.122.826 $ | -65,7 % | 1 | 47.406.842 $ | +17.576.560 $ | +58,9 % | 1 |
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 21.242.953 $ | +1.809.861 $ | +9,3 % | 1 | 19.433.092 $ | +15.938.643 $ | +456,1 % | 1 | 3.494.449 $ | +721.966 $ | +26,0 % | 1 |
| Alto Neuroscience, Inc. | ANRO | → 0 | Neutral | 15.011.649 $ | +3.125.201 $ | +26,3 % | 1 | 11.886.448 $ | +9.201.980 $ | +342,8 % | 1 | 2.684.468 $ | +1.215.356 $ | +82,7 % | 1 |
| Korro Bio, Inc. | KRRO | → 0 | Neutral | 3.133.727 $ | +916.311 $ | +41,3 % | 1 | 2.217.416 $ | -11.040.021 $ | -83,3 % | 1 | 13.257.437 $ | +9.799.818 $ | +283,4 % | 1 |
| Caribou Biosciences, Inc. | CRBU | → 0 | Schwach | 900.727 $ | +146.960 $ | +19,5 % | 1 | 753.767 $ | -350.809 $ | -31,8 % | 1 | 1.104.576 $ | +507.252 $ | +84,9 % | 1 |
| 49.601.478 $ | -973.261 $ | +10,7 % | 5 | 50.574.739 $ | -17.373.033 $ | +123,6 % | 5 | 67.947.772 $ | +29.820.952 $ | +107,2 % | 5 | ||||